Oruka Therapeutics, Inc. · NASDAQ:ORKA
Goncalves Joana sold 7,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded Aug 17, 2026 · Filed Aug 17, 2026
On Aug 17, 2026, Goncalves Joana (Chief Medical Officer) sold 7,000 Oruka Therapeutics, Inc. shares at an average US$111.84 for US$783K under a trading plan, leaving 32,718 shares. Filed Aug 17, 2026 (Form 4).
- Sold
- 7,000 shares
- Price
- US$111.84 average (US$109.65 to US$112.56)
- Value
- US$783K
- Holding after
- 32,718 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | Option exercise | 3,500 | US$6.84 | 36,218 | Direct |
| Aug 17, 2026 | Common Stock | Option exercise | 3,500 | US$7.80 | 39,718 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 900 | US$109.65 | 38,818 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 300 | US$110.52 | 38,518 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 3,320 | US$112.01 | 35,198 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 2,480 | US$112.56 | 32,718 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Goncalves Joana
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Goncalves Joana · Sep 15, 2026
- Form 4 · Goncalves Joana · Jul 15, 2026
- Form 4 · Goncalves Joana · Jun 15, 2026
- Form 4 · Goncalves Joana · May 15, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026
- Form 4 · Agarwal Arjun · Sep 21, 2026